BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1692180)

  • 21. The use of hematopoietic growth factors in HIV infection and AIDS-related malignancies.
    Miles SA
    Cancer Invest; 1991; 9(2):229-38. PubMed ID: 1713806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report.
    Garavelli PL
    Haematologica; 1992; 77(3):293-4. PubMed ID: 1385275
    [No Abstract]   [Full Text] [Related]  

  • 23. Hematopoietic growth factors as adjuncts to antiretroviral therapy.
    Miles SA
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1073-80. PubMed ID: 1380256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
    Moreno García M; Fernández González F
    Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
    [No Abstract]   [Full Text] [Related]  

  • 25. Erythropoietin for zidovudine-induced anemia.
    N Engl J Med; 1990 Oct; 323(15):1069-70. PubMed ID: 2215568
    [No Abstract]   [Full Text] [Related]  

  • 26. Review of current therapy in human immunodeficiency viral infections.
    Gulick PG
    J Am Osteopath Assoc; 1988 Aug; 88(8):998-1002. PubMed ID: 3065311
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of hematopoietic hormones for bone marrow defects in AIDS.
    Aboulafia DM
    Oncology (Williston Park); 1997 Dec; 11(12):1827-34, 1839, 1843-4; discussion 1. PubMed ID: 9436189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anemia in AIDS: the problem to avoid. Human recombinant erythropoietin in the treatment of HIV positive patients].
    Karwacki M; Ochocka M; Kubiak W
    Przegl Epidemiol; 1994; 48(4):441-7. PubMed ID: 7597181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematologic abnormalities in AIDS.
    Aboulafia DM; Mitsuyasu RT
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):195-214. PubMed ID: 2022589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of cytokines in human immunodeficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2.
    Armstrong WS; Kazanjian P
    Clin Infect Dis; 2001 Mar; 32(5):766-73. PubMed ID: 11229845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical applications of colony-stimulating factors in acquired immunodeficiency syndrome.
    Scadden DT
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):33-7. PubMed ID: 1492232
    [No Abstract]   [Full Text] [Related]  

  • 32. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
    Garavelli PL; Berti P
    Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Erythropoietin treatment of anemia associated with human immunodeficiency virus infection].
    Moreno García M
    Med Clin (Barc); 1997 Feb; 108(7):266-71. PubMed ID: 9121196
    [No Abstract]   [Full Text] [Related]  

  • 34. Recombinant human granulocyte-macrophage colony-stimulating factor in AIDS.
    N Engl J Med; 1988 Mar; 318(9):579-80. PubMed ID: 3277058
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo effects of recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF), alone and associated with zidovudine, on HIV-1 replication.
    Manfredi R; Re MC; Furlini G; Gorini R; Chiodo F
    New Microbiol; 1997 Oct; 20(4):345-50. PubMed ID: 9385605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stem cell-colony stimulating factors].
    Urabe A; Kobayashi Y; Takaku F
    Gan No Rinsho; 1989 May; Spec No():287-93. PubMed ID: 2481048
    [No Abstract]   [Full Text] [Related]  

  • 37. Zidovudine for the treatment of HIV infection.
    Pepe R; Molavi A
    Am Fam Physician; 1990 Aug; 42(2):437-43. PubMed ID: 2200250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [GM-CSF: its use in onco-hematologic diseases].
    Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
    Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of recombinant hematopoietic growth factors in blood diseases.
    Jimenez JJ; Vargas-Cuba R; Temple JD
    Adv Intern Med; 1990; 35():393-414. PubMed ID: 2405600
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost considerations in therapy with myeloid growth factors.
    Glaspy JA; Jakway J
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S19-26. PubMed ID: 7689789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.